Facebook Pixel Putin's visit is an opportunity to recalibrate relations with Russia | Mint Chennai - newspaper - Magzter.comでこの記事を読む
Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

Putin's visit is an opportunity to recalibrate relations with Russia

Mint Chennai

|

December 04, 2025

New Delhi and Moscow need to look beyond the past in a rapidly evolving geopolitical context

- KANICA RAKHRA

This week’s visit to India of Russia's President Vladimir Putin has drawn New Delhi's long relationship with Moscow into the spotlight.

The India-Russia bond has been strong and steady, as evident in the fact that it has outlasted many shifts in global geopolitics. Looking at the cooperation between the two, whether it is on defence materiel or navigating past twists and turns in the global order, India and Russia have understood each other's requirements and managed to support each other in their time of need. But is the relationship ready for a new wave of geopolitical shifts?

The 1971 Indo-Soviet Treaty of Friendship and Cooperation paved the way for India-Russia relations where both could benefit from bilateral ties. Moscow supported India in multilateral forums with its veto power and New Delhi bought its defence equipment from the Russian Federation (or Soviet Union before it split). The relationship also had soft-power elements, with Indian movie actors finding popularity in Russia and the latter being a popular destination for Indian medical students.

In the 2000s, Russia’s support for the India-US nuclear deal as well as for India’s membership of the Nuclear Suppliers Group assisted New Delhi in its negotiations at various levels. This led to a new dawn in the relationship between the US and India, making space for an enhanced global role for New Delhi. But this new role was not to be at the cost of its ties with Russia.

Mint Chennai からのその他のストーリー

Mint Chennai

Mint Chennai

Barrier-free tolling runs into a Chinese camera security bump

Commuters looking to zoom past toll plazas on India's 146,560 km highway network will have to wait longer.

time to read

1 min

February 26, 2026

Mint Chennai

A new grammar to challenge Tamil film

Members of the Problematic Family, which premiered at the Berlinale, is a striking, experimental debut film from R. Gowtham

time to read

3 mins

February 26, 2026

Mint Chennai

AUROBINDO PHARMA TAKES A PENICILLIN SHOT

The company has made a ₹2,500 crore bet to rebuild its antibiotic backbone. Will it work?

time to read

6 mins

February 26, 2026

Mint Chennai

Digital rupee pilot for food subsidy

In a significant shift in the way food subsidies are delivered, the government will launch a central bank digital currency (CBDC)-based pilot under the Pradhan Mantri Garib Kalyan Anna Yojana (PMGKAY) in Puducherry on 26 February.

time to read

1 min

February 26, 2026

Mint Chennai

DRL's obesity jab may launch in March

Dr. Reddy's Laboratories (DRL) is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the matter as well as images reviewed by Reuters.

time to read

1 min

February 26, 2026

Mint Chennai

Mint Chennai

Uranium supply deal likely during Carney’s India visit

Cameco CEO Tim Gitzel to be part of the business delegation accompanying Canadian PM

time to read

2 mins

February 26, 2026

Mint Chennai

Mint Chennai

Warner interested in Paramount offer

Warner Bros Discovery Inc. said a new $31-a-share buyout offer from Paramount Skydance Corp. could lead to a better deal than its existing agreement with Netflix Inc., kicking off another potential round of bidding for the famed Hollywood studio.

time to read

1 mins

February 26, 2026

Mint Chennai

Mint Chennai

Hype and havoc shroud Al's impact on IT firms

Is investor anxiety over the business models of IT service companies being rendered obsolete by AI overblown? The truth lies between an apocalypse and AI-impact denial. Here's why

time to read

2 mins

February 26, 2026

Mint Chennai

Mint Chennai

Zydus plans obesity jab in pens after semaglutide patent ends

Ahmedabad-based drugmaker Zydus Lifesciences plans to launch its semaglutide injection brands upon patent expiry of the drug in India.

time to read

1 mins

February 26, 2026

Mint Chennai

Mint Chennai

CHASING 12% EQUITY RETURNS? LONG-TERM INVESTING ISN'T JUST ABOUT A NUMBER

Most investors enter equity mutual funds expecting an annual average return of about 12%.

time to read

3 mins

February 26, 2026

Listen

Translate

Share

-
+

Change font size